Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial

scientific article published on 09 October 2020

Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/OPTH.S263362
P932PMC publication ID7555274
P698PubMed publication ID33116367

P50authorLyndon JonesQ47435964
Elizabeth YeuQ90668826
Steven SilversteinQ99565091
Michel GuillonQ99565092
David GalarretaQ99565094
Joseph TauberQ101051523
Sruthi SrinivasanQ101051524
P2093author name stringVenkiteshwar Manoj
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P921main subjecteye diseaseQ3041498
P304page(s)3167-3177
P577publication date2020-10-09
P1433published inClinical OphthalmologyQ5133782
P1476titleSymptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial
P478volume14

Search more.